Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- Pediatric Pulmonary Hypertension
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Masking Description: the researchers don't know which drug taken by the patient and don't know the previous PA pressurePrimary Purpose: Treatment
Participation Requirements
- Age
- Between 1 years and 17 years
- Gender
- Both males and females
Description
Eligibility criteria: Inclusion: children aged 1-17 years with left to right shunt, diagnosed as pulmonary hypertension. free from chronic pulmonary disease never performed any cardiac surgical never got any treatment for PH agree to enroll in this study. Exclusion 1. suffer from portal hypertension...
Eligibility criteria: Inclusion: children aged 1-17 years with left to right shunt, diagnosed as pulmonary hypertension. free from chronic pulmonary disease never performed any cardiac surgical never got any treatment for PH agree to enroll in this study. Exclusion 1. suffer from portal hypertension, HIV and connective tissue disease 2. under interferon therapy. Outcome measure: Pulmonary artery pressure
Tracking Information
- NCT #
- NCT03431649
- Collaborators
- Not Provided
- Investigators
- Study Director: Mahrus Rachman, MD Dr. Soetomo General Hospital
Get Well Soon